CVS Caremark的动态

Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs Explore the significance of Ready-To-Use cartridges for GLP-1-based drugs and learn about the major challenge of ensuring compatibility among the drug, container, and device. Read the full article to learn more about how auto-injectors and pen injectors are user-friendly options for variable and multi-dose treatments. Link in the comments?? Stevanato Group #glp1 #readytousecartridges

Medicare has announced another 15 expensive drugs (now total 25) undergoing price negotiation with manufacturers. Enbrel and Stelara were in the 1st ten. Included in the next 15 Rx are Ofev (nintenib) & Otezla (apremilast) & GLP-1 drugs. https://buff.ly/40Gqdcw https://buff.ly/40nwYyr

Can an endoscopic procedure help patients maintain lower weight after stopping GLP-1 treatment? In prior clinical trials of Revita for patients with #T2D we saw sustained weight loss for as long as 2 years after treatment (https://ir.fractyl.com/). We are now testing Revita as a potential solution for patients who lose weight on #GLP-1 drugs and want to discontinue chronic medication, in our Remain-1 study. https://lnkd.in/eT7gP5Af I am beyond gratified that Revita for weight maintenance is now included in the FDA's Breakthrough Devices Program. #obesity #type2diabetes

Wondering how to save on your next trip to the pharmacy? Try replacing your brand-name drugs with generics. Watch this video to learn more with Tip #3 in our Pharmacy Savings series: Use Generic Drugs.

This rich presentation made by PDA (Parenteral Drugs Association) describes in a very interesting way the visual inspection for injectable products. #qualitycontrol #qualityassurance

For those deep down the #GLP1 rabbit hole, here's a great writeup by Axios on when (if ever) we might see competition drive down cost. ?? LINK IN COMMENTS ?? A few quick highlights: ?? Major relief isn't coming anytime soon (sorry) ?? Competition between manufacturers will likely create some reduction in the mid-term ?? If drug companies treat GLP-1s like statins, the cost will come down eventually as generics appear on the market, but if they treat it like insulin and find ways around patent expiration dates, then costs will likely remain high for a while The full article is still an interesting read as it shares context around drug pricing over time. #employeebenefits #pbm #pharmacy

Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG ? Achieving JPY 5 billion Net Sales in Japan

$HEC CJ PHARM (01558.HK)$Signed a strategic cooperation agreement with$3SBIO (01530.HK)$A subsidiary signed a licensing agreement for the authorized use of benzenesulfonic acid crizotinib. https://lnkd.in/gHMeh56f

Cannabis slashes opioid prescriptions by 53% Meet Quantum 1 Cannabis (QQ: CSE) (QQQFF: OTC) ?? 2023 Revenue: $7.4M ?? 3 profitable Cannabis stores in British Colombia https://lnkd.in/g9a-4Gwq #smallcaps #pennystocks #smallcapstocks #smallcap #cannabis

This month, let’s talk about the “Miracle Drug” for weight loss that is making waves! For this week, know that these wonder drugs mimic GLP-1. And GLP-1 is a hormone that controls your sugar and hunger. So, these drugs can help manage both Type 2 diabetes and Obesity. Read more about GLP-1 here.